FDA-cleared profile

BoneMRI

MRIguidance B.V

MRI-based BoneMRI image enhancement for visualizing pelvic and cervical, thoracic, lumbar and S1 spinal bone structures with CT-like radiodensity contrast; not for tumor diagnosis or monitoring and not a CT replacement.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
MRI-based BoneMRI image enhancement for visualizing pelvic and cervical, thoracic, lumbar and S1 spinal bone structures with CT-like radiodensity contrast; not for tumor diagnosis or monitoring and not a CT replacement.
FDA source Exact FDA submission Checked 2026-09-07
Intended users
Imaging experts such as radiologists or orthopedic surgeons.
FDA source Exact FDA submission Checked 2026-09-07
Care setting and population
Physician-office and clinic or hospital MRI/PACS workflows; indicated for patients 12 years and older.
FDA source Exact FDA submission Checked 2026-09-07
Workflow role
Standalone MRI image-processing server that creates an adjunctive bone-visualization series while the original DICOM study remains available for standard interpretation.
FDA source Exact FDA submission Checked 2026-09-07
Required input
DICOM 3D gradient-echo MRI images acquired using a dedicated MRI protocol.
FDA source Exact FDA submission Checked 2026-09-07
Output and human action
DICOM BoneMRI images for viewing in a regular DICOM-compatible viewer, with 3D bone morphology, tissue radiodensity and tissue-radiodensity contrast visualized alongside the original images.
FDA source Exact FDA submission Checked 2026-09-07
Limitations
Not for diagnosis or monitoring of primary or metastatic tumors; BoneMRI images are not intended to replace CT in general. Clinicians must interpret the enhanced images with the original study.
FDA source Exact FDA submission Checked 2026-09-07

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K233030
FDA source Exact FDA submission Checked 2026-08-31
Modality
MRI
FDA source Exact FDA submission Checked 2026-09-07
Anatomy
Spine
FDA source Exact FDA submission Checked 2026-09-07

The exact indication also includes the pelvic region; the controlled directory anatomy is normalized to Spine.

Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2024-03-01
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
Communicates with a DICOM-compatible imaging archive such as PACS to receive MRI input and return BoneMRI images; regular DICOM viewing software displays the result, while receipt and delivery depend on other software systems.
FDA source Exact FDA submission Checked 2026-09-07
Deployment and data flow
Server application on clinic or hospital networks, available fully on premises with specific GPU requirements or partly as a managed cloud service. The FDA summary states that on-premise PHI stays within the network and data sent to the managed cloud is de-identified before leaving it.
FDA source Exact FDA submission Checked 2026-09-07

Deployment language is from the exact FDA submission; it does not establish a current contracted hosting or security configuration.

Security and privacy
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-07

The FDA deployment description does not establish formal security controls for a current installed configuration.

Training and support
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13

Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.

Monitoring and change control
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13

Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.

Exact deployment and DICOM/PACS path

The FDA summary describes on-premise or partly managed-cloud server deployment and DICOM archive/PACS input and return, with output viewed in regular DICOM software.

exact submission · checked 2026-09-07

Current BoneMRI family PACS and scanner workflow

MRIguidance's current BoneMRI family page describes 3D CT-like images reconstructed from MRI, forwarding reconstructed images to PACS, and compatibility with major MRI scanners.

product family · checked 2026-09-07

Current family material is buyer-relevant workflow context but does not establish feature parity or release identity for K233030.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
K233030 BoneMRI was validated with paired BoneMRI and CT images from 76 pelvic and 117 spine patients. The FDA summary reports bounds for morphology and radiodensity agreement, not exact aggregate point estimates.
FDA source Exact FDA submission Checked 2026-09-07
Reported sensitivity
Research pending
Needs research Exact FDA submission Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
Needs research Exact FDA submission Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K233030 BoneMRI quantitative voxel-by-voxel validation

Quantitative validation using paired BoneMRI and CT images from previously conducted clinical investigations; test data were unseen during development. · 76 patients with pelvic-region data and 117 patients with spine-region data.

exact submission · Tested version: BoneMRI release reviewed in FDA submission K233030 · n=193 · Independence not established

K233030

Validation was conducted by MRIguidance; independent-investigator status was not established.

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-07

No public exact-submission price or procurement terms were reviewed.

Reimbursement and coding
Research pending
Needs research Exact FDA submission Checked 2026-09-07

CMS policy research was not performed by this worker; no coverage conclusion is made.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-07Last searched
24Fields reviewed
11Source classes checked
18Reviewed PubMed leads
2Reviewed trial leads
0Unreviewed FDA recall leads

The stored PubMed and ClinicalTrials candidate metadata were screened in the exact stored order; this was metadata triage, not full-text paper or registry-record review, and no candidate was promoted. The stored recall query returned no records, so no event was promoted and no absence claim is made. The current discovery snapshot contains 18 PubMed and 2 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, literature index, trial registry, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-07.

Alternatives

Related tools to compare

FDA-cleared K230197

BoneMRI v1.6

MRIguidance B.V.

MRI-based BoneMRI v1.6 image enhancement for visualizing pelvic and L3-S1 lumbar bone structures with enhanced contrast; not for tumor diagnosis or monitoring and not a CT...

Modality
MRI
Anatomy
Spine
Decision
2023-02-22
FDA-cleared K220497

CoLumbo

Smart Soft Healthcare AD

CoLumbo is an image post-processing and measurement software tool that provides quantitative spine measurements from previously-acquired DICOM lumbar spine Magnetic Resonance (MR)...

Modality
MRI
Anatomy
Spine
Decision
2022-06-23